VT
Viridian Therapeutics Inc
🇺🇸XNAS.VRDNUnited StatesHealthcare
$21.75USDdown -0.04 (-0.18%)OpenDelayed3:33 PM
Price$21.75-0.04 (-0.18%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92790C1045
- CUSIP
- 92790C104
Company
- Employees
- 252
- Headquarters
- Waltham, United States
- CEO
- Mr. Stephen F. Mahoney J.D., MBA
Market
- Shares outstanding
- 113.3M
- Market cap
- $2.46B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $2.47B
- EPS LTM
- -$3.59
- P/E LTM
- -5.22
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $71.13M+23,220.33%up year on year
- Net income
- -$386.97M-12.47%down year on year
- Gross margin
- 99.22%+66.27%up year on year
- Free cash flow
- -$335.04M-8.22%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.